These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8420051)

  • 1. A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation--immunosuppressive activity and side effects.
    Elli A; Rivolta R; Di Palo FQ; Parenti M; Vergallo G; Palazzi P; Zafiropulu S; Abelli P; Zanussi C
    Transplantation; 1993 Jan; 55(1):209-12. PubMed ID: 8420051
    [No Abstract]   [Full Text] [Related]  

  • 2. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
    Elli A; Rivolta R; Palazzi P; Mascaretti L; Puglisi G; Parenti M; Sioli V; Di Palo FQ
    Transplant Proc; 1990 Aug; 22(4):1689-90. PubMed ID: 2202126
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive activity of deflazacort vs methylprednisolone in renal transplantation: effects on lymphocyte subsets.
    Elli A; Rivolta R; Mascaretti L; Parenti M; Palazzi P; Quarto Di Palo F; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1122-4. PubMed ID: 1989164
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of corbrin capsule in human renal transplantation.
    Min Z; Oi J; Zhu Y; Wei W
    Transplant Proc; 1996 Jun; 28(3):1626-8. PubMed ID: 8658813
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary experience with deflazacort, a new synthetic steroid with fewer undesirable side effects, in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; Montero A; Sancho M; López-Rubio F; Latre JM; Calleja F; Casares J; Román M
    J Heart Lung Transplant; 1993; 12(3):445-8; discussion 448-9. PubMed ID: 8329416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
    Gross V; Andus T; Caesar I; Bischoff SC; Lochs H; Tromm A; Schulz HJ; Bär U; Weber A; Gierend M; Ewe K; Schölmerich J
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):905-9. PubMed ID: 8889459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of combined intravenous pulse methylprednisolone and low-dose oral cyclosporin A in the treatment of corneal graft rejection: addendum to previous report.
    Wong AK; Tham CC; Leung AT; Lam DS
    Eye (Lond); 1999 Aug; 13 ( Pt 4)():584-5. PubMed ID: 10692936
    [No Abstract]   [Full Text] [Related]  

  • 9. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-hour immunologic assessment of CD4+ and CD8+ lymphocytes in renal transplant recipients receiving chronic methylprednisolone.
    Tornatore KM; Reed K; Venuto R
    Clin Nephrol; 1995 Nov; 44(5):290-8. PubMed ID: 8605708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

  • 12. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of deflazacort, a glucocorticoid with bone-sparing properties, on mixed lymphocyte response and skin graft rejection.
    Mistrello G; Mapelli E; Galliani G; Cristina T; Assandri A
    Transplantation; 1984 Aug; 38(2):192-4. PubMed ID: 6235649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does preoperative corticoid administration reduce the incidence of acute rejections after kidney transplantation?].
    Strik MW; Klüter H; Hoyer J; Bruch HP; Sack K; Fricke L
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1035-8. PubMed ID: 9574324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of first acute rejection episode and severity of rejection on cadaveric renal allograft survival.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Dec; 10(6 Pt 1):538-41. PubMed ID: 8996775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation.
    Ferraris JR; Sorroche P; Legal S; Oyhamburu J; Brandi P; Pasqualini T
    J Pediatr; 1998 Oct; 133(4):533-6. PubMed ID: 9787693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corneal graft rejection and corticoid iontophoresis: 3 case reports].
    Halhal M; Renard G; Bejjani RA; Behar-Cohen F
    J Fr Ophtalmol; 2003 Apr; 26(4):391-5. PubMed ID: 12843898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with a new glucocorticoid: effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.
    Ferraris JR; Pasqualini T
    J Rheumatol Suppl; 1993 Apr; 37():43-6. PubMed ID: 8501752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative application of glucocorticosteroids efficaciously reduces the primary immunological response in kidney transplantation.
    Fricke L; Klüter H; Feddersen A; Doehn C; Steinhoff J; Hoyer J; Sack K
    Clin Transplant; 1996 Oct; 10(5):432-6. PubMed ID: 8930457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.